The aim of present research was to study the comparative action of continuous subcutaneous insulin injection (CSII) and continuous glucose monitoring (CGM) in patients with diabetes mellitus (DM) 1 and 2 type on the level of glycosylated haemoglobin (HbA1с) and fructosamine.
CSII alone and in combination with CGM could significantly decrease the level of fructosamin in the patients with DM 1 and DM 2 type. Combination of multiple daily insulin injections with CGM in the patients with DM 1 and DM 2 type decreased level of HbA1с, but without compensation. Usage of CSII in patients with DM 2 type provided subcompensation state according to HbA1с. Finally, combination of CSII with CGM in the patients with DM 1 and DM 2 type allowed to reach recommended level of glycosylated haemoglobin — under 6.5% that will prevent and delay development of diabetic vascular complications.